How do you manage a muscle-invasive bladder cancer patient who received neoadjuvant cisplatin-based chemotherapy but has a positive margin post-operatively?
Would you consider adjuvant RT vs chemoRT vs additional chemotherapy vs adjuvant immunotherapy?